Das vorliegende Positionspapier analysiert und bewertet die gegenwärtigen Rahmenbedingungen zur Überführung innovativer Medizinprodukte in die Kostenerstattung durch die Gesetzliche Krankenversicherung in Deutschland.
This position paper is an initiative by the Expert Committee Methodology of Patient Monitoring
(Fachausschuss Methodik der Patientenüberwachung) in the German Society for Biomedical
Engineering of the VDE (DGBMT)
Das VDE-Positionspapier aus dem DGBMT-Fachausschuss Methodik der Patientenüberwachung fasst die Ergebnisse eines im Oktober 2010 durchgeführten Workshops zusammen.
European sovereignty of medical technologies (MT) and biomedical engineering (BME) is necessary to ensure utmost quality of healthcare, as laid out not only in the German constitution. It is important
to maintain and further expand the current high medical-technical standard through thoroughly developed
and mastered sovereign technologies and at the same time medical professionals trained at the highest technical level to be able to safely apply these technologies. This seems to be the only way to maintain sovereignty and shape, achieve the social and economic goals of the health care sector in the future.